Locally-owned MedSpa celebrates 15 years
Derma Health Skin & Laser, locally-owned and operated since 2004, celebrates 15 years of service in the Valley. More than 50,000 patients have received treatments and services at the full-service medical spa. Derma Health offers laser, skin and body treatments, Botox, dermal fillers, body contouring and medical grade aesthetic services at its five Valley locations. The MedSpa is ranked as the top 1 percent in the nation by Allergan and is the No. 1 provider of facial fillers and Botox in the Southwest. Over 5,000 Botox and filler injections are administered each month.
“I started this journey to help women of all ages look as beautiful and vibrant on the outside as they do on the inside,” said Founder and CEO of Derma Health, Trish Gulbranson. “Our dedication to safety and quality care through highly-trained medical professionals, as well as educating and empowering clients, has created what we like to call the Derma Health difference.”
Staffed with doctors, registered nurses and aestheticians, Derma Health is committed to providing its personnel with ongoing training in the most advanced techniques in all services. The aestheticians alone have more than 73 years of combined experience. Staff members are not only focused on skin and physical appearance, but overall health and wellbeing too. Derma Health’s mission is to uplift, inspire and encourage people to be the very best they can be.
“My goal is to help patients reach their health, wellness and aesthetic goals safely and effectively,” said Dr. Margaret Husami, NMD, who works out of the Mesa location. “I believe in a holistic continuum of care from prevention to correction with the least invasive and most natural treatments possible to enhance beauty, inside and out.”
ProNeurogen’s new drug candidate shows promise
Cognitive impairment affects more than 50 million people worldwide. In the United States alone, one in three seniors dies with some type of dementia. This creates a critical clinical need for safe and effective therapies for the treatment and prevention of cognitive impairment. Tucson-based ProNeurogen, Inc. published this week findings relating to its novel drug candidate for treating cognitive impairment associated with vascular dementia and non-Alzheimer’s related dementias. The paper, titled A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation Related Memory Dysfunction, was published in the Journal of Pharmacology and Experimental Therapeutics.
“This novel drug candidate represents a first-in-class therapeutic with great promise for improving the cognitive impairment of millions of individuals,” said Dr. Meredith Hay, a co-inventor of the technology, Chief Science Officer and Founder of ProNeurogen, and a professor at the University of Arizona. “The PNA-5 drug candidate is a major therapeutic breakthrough for treating inflammatory processes linked to cognitive impairment.”
After Alzheimer disease, vascular dementia is the most common form of dementia. It is involved in nearly half of all dementia cases. Risk factors for vascular dementia include cerebrovascular disease (hypertension, diabetes, hyperlipidemia, heart failure) and coexisting conditions related to atherosclerosis (coronary artery disease, peripheral artery disease). Other non-Alzheimer’s related dementias relating to brain inflammation include those dementias associated with, for example, pre-Alzheimer’s, Multiple Sclerosis and Parkinson’s Disease.
Republic Services named to World’s Most Ethical Companies list
Republic Services, Inc. announced its inclusion on the 2019 World’s Most Ethical Companies® List by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. Republic is the sole recycling and solid waste services provider to be honored with this recognition.
“It is truly an honor to be recognized again as one of Ethisphere’s World’s Most Ethical Companies,” said Don Slager, president and chief executive officer. “We believe it’s our responsibility to lead by example, holding ourselves to the highest ethical standards in all that we do. We owe this to our employees, customers, communities and shareholders.”
The 2019 list honors 128 companies spanning 21 countries and 50 industries. These corporations illustrate how companies can be the driving force for improving communities, building capable and empowered workforces, and fostering corporate cultures focused on ethics and a strong sense of purpose.
“We congratulate our 36,000 employees for achieving this honor for the third consecutive year,” said Catharine Ellingsen, executive vice president, chief legal officer and chief ethics and compliance officer. “This recognition speaks to the culture of Republic Services and exemplifies our employees’ shared commitment to making ethics and compliance a priority in their everyday actions and decisions.”
PathogenDx launches new brand and microbial testing products
PathogenDx, Inc., the Scottsdale-based technology company, which provides a DNA-based customized pathogen testing platform for the Cannabis industry, announced today a new corporate brand identity, logo and product portfolio. These changes come at a time when the company is extending its platform with new products and evolving from its Cannabis only focus to new industries.
In making the announcement, CEO and Co-Founder Milan Patel said, “PathogenDx’s mission is to disrupt a century-old process of product testing by leveraging our breakthrough DNA-based microbial testing technology platform to set the standard in product safety. We’re making the accurate testing of Cannabis, food and agriculture faster, more definitive and less expensive with trackable results benefitting growers, producers, regulators and consumers worldwide. Our new brand is inspired by our unique microplex array and is bright, fresh, memorable and expansive, enabling us to move from Cannabis only to much larger global consumable markets where we can continue to offer new products and applications for the technology.”
In changing its brand identity for global markets, PathogenDx also announced its portfolio of products with new names and brand identities as well.